Pending no delays on delivery, Tox data, and recruitment (all comers trials so can’t see why we would have issues here) then we could very well be climbing past ATH in Q4.
Unless RAC choose to keep cards close on what they observe until P2 which would be extremely frustrating.
@Davisite if positive and there’s validity around cardio protection or Anti cancer via inhibition, do RAC have to report on this?
Pending no delays on delivery, Tox data, and recruitment (all...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
-0.055(3.79%) |
Mkt cap ! $237.8M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.45 | $1.33 | $213.7K | 155.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 55 | $1.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 7167 | 1 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |